Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Endocrine 1Breast 1

Conditions

Neuroendocrine Tumors 1Breast Neoplasms 1

Interventions

pembrolizumab 592Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 508Specimen Handling 504Nivolumab 408Cisplatin 370Carboplatin 359Biopsy 304Blood Specimen Collection 295Radiosurgery 284Paclitaxel 274Surveys and Questionnaires 268Gemcitabine 267Standard of Care 266fludarabine 261Dexamethasone 258Drug Therapy 257venetoclax 247Bevacizumab 246Oxaliplatin 206Rituximab 196Capecitabine 196Radiation 189Fluorouracil 186Ipilimumab 185durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × 68Ga-FAPI × 1 year × Clear all
NCT07553741 2026-04-28

Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡